Statistics for Vivoryon Therapeutics N.V. (id:79 VVY)
Valuation metrics
Market cap
51.77M
Enterprise value
35.83M
Trailing P/E (ttm)
Forward P/E
-2.63
PEG ratio
-2.63
Price/Sales (ttm)
-14.30
Price/Book (mrq)
3.68
Enterprise Value/Revenue
-9.90
Enterprise Value/EBITDA
-1.15
Overview
Shares outstanding
26.07M
Float
21.16M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
482.88K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
9.93
52-Week change
-324.87%
Beta
1.99
50-Day moving average
2.14
200-Day moving average
1.81
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
85.50%
Operating margin
866.13%
Operational effectiveness
Return on assets
-62.86%
Return on equity
-112.35%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
-3,095,000.00
EBITDA
-31,265,000.00
Net income to common (ttm)
-31,185,000.00
Diluted EPS (ttm)
-1.20
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
15.27M
Total cash per share (mrq)
3.00
Total debt (mrq)
10.00K
Total Debt/Equity (mrq)
5.00
Current ratio (mrq)
937.30%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-14,558,000.00
Levered free cash flow (LFCF)
-12,254,750.00